The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2025

Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2002867

No of Pages : 100

Ask Your Query
Synopsis
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was valued at US$ 6500 million in the year 2024 and is projected to reach a revised size of US$ 9639 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Clinical reference laboratory molecular diagnostic services refer to the analysis of biological samples (such as blood, tissue, etc.) of patients through molecular biology techniques (such as PCR, gene sequencing, etc.) to detect genetic material (DNA, RNA) changes related to diseases, thereby providing scientific basis for disease diagnosis, treatment, and prognosis. Its application areas include disease diagnosis, drug development, personalized medicine, forensic identification, etc.
In recent years, the market size of clinical reference laboratory molecular diagnostic services has been continuously growing. The main driving factors include the application of new technologies such as high-throughput sequencing and digital PCR, the gradual popularization of personalized medicine, the increasing demand for diagnostic testing services, and policy support from governments around the world. In the global market, international giants such as Quest Diagnostics, Eurofins Scientific, and Genomic Health. In the Chinese market, local enterprises such as BGI Genomics and Daan Genomics have gradually enhanced their competitiveness through technological innovation and market expansion. In the future, the development trend of the market lies in intelligence and automation, multi omics integration, remote healthcare, and home testing. Specifically, the laboratory will introduce more automated equipment and artificial intelligence technology to improve detection efficiency and accuracy, while combining genomic, proteomic, and metabolomic data to provide a more comprehensive disease diagnosis plan. With the popularization of technology, molecular diagnostic services will be extended to households and communities to meet the needs of more scenarios.
This report aims to provide a comprehensive presentation of the global market for Clinical Reference Laboratory Molecular Diagnostic Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Reference Laboratory Molecular Diagnostic Services.
The Clinical Reference Laboratory Molecular Diagnostic Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Reference Laboratory Molecular Diagnostic Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Reference Laboratory Molecular Diagnostic Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quest Diagnostics
Eurofins Scientific
Mayo Clinic Laboratories
Genomic Health
Clinical Reference Laboratory
Molecular Pathology Laboratory Network
Opko Health
NantHealth
ARUP Laboratories
Viant Medical
Sonic Healthcare
Fulgent Genetics
Laboratory Corporation of America Holdings
BGI Genomics
Daan Gene
Guangdong Hybribio Biotech
Jiangsu Bioperfectus Technologies
Maccura Biotechnology
Guangzhou Wondfo Biotech
GoBroad Healthcare
Segment by Type
Nucleic Acid Amplification Testing
Nucleic Acid Hybridization Testing
Gene Sequencing
Gene Chip Technology
Others
Segment by Application
Disease Diagnosis
Drug Development
Personalized Healthcare
Medicolegal Expertise
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Reference Laboratory Molecular Diagnostic Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nucleic Acid Amplification Testing
1.2.3 Nucleic Acid Hybridization Testing
1.2.4 Gene Sequencing
1.2.5 Gene Chip Technology
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Disease Diagnosis
1.3.3 Drug Development
1.3.4 Personalized Healthcare
1.3.5 Medicolegal Expertise
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Perspective (2020-2031)
2.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Growth Trends by Region
2.2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Region (2020-2025)
2.2.3 Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Region (2026-2031)
2.3 Clinical Reference Laboratory Molecular Diagnostic Services Market Dynamics
2.3.1 Clinical Reference Laboratory Molecular Diagnostic Services Industry Trends
2.3.2 Clinical Reference Laboratory Molecular Diagnostic Services Market Drivers
2.3.3 Clinical Reference Laboratory Molecular Diagnostic Services Market Challenges
2.3.4 Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Revenue
3.1.1 Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Revenue (2020-2025)
3.1.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Reference Laboratory Molecular Diagnostic Services Revenue
3.4 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Concentration Ratio
3.4.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Reference Laboratory Molecular Diagnostic Services Revenue in 2024
3.5 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services Head office and Area Served
3.6 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Product and Application
3.7 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Reference Laboratory Molecular Diagnostic Services Breakdown Data by Type
4.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Type (2020-2025)
4.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Type (2026-2031)
5 Clinical Reference Laboratory Molecular Diagnostic Services Breakdown Data by Application
5.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Application (2020-2025)
5.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
6.2 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025)
6.4 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
7.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025)
7.4 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
8.2 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
9.2 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025)
9.4 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size (2020-2031)
10.2 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.1.4 Quest Diagnostics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.1.5 Quest Diagnostics Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.2.4 Eurofins Scientific Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Mayo Clinic Laboratories
11.3.1 Mayo Clinic Laboratories Company Details
11.3.2 Mayo Clinic Laboratories Business Overview
11.3.3 Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.3.4 Mayo Clinic Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.3.5 Mayo Clinic Laboratories Recent Development
11.4 Genomic Health
11.4.1 Genomic Health Company Details
11.4.2 Genomic Health Business Overview
11.4.3 Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.4.4 Genomic Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.4.5 Genomic Health Recent Development
11.5 Clinical Reference Laboratory
11.5.1 Clinical Reference Laboratory Company Details
11.5.2 Clinical Reference Laboratory Business Overview
11.5.3 Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.5.4 Clinical Reference Laboratory Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.5.5 Clinical Reference Laboratory Recent Development
11.6 Molecular Pathology Laboratory Network
11.6.1 Molecular Pathology Laboratory Network Company Details
11.6.2 Molecular Pathology Laboratory Network Business Overview
11.6.3 Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.6.4 Molecular Pathology Laboratory Network Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.6.5 Molecular Pathology Laboratory Network Recent Development
11.7 Opko Health
11.7.1 Opko Health Company Details
11.7.2 Opko Health Business Overview
11.7.3 Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.7.4 Opko Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.7.5 Opko Health Recent Development
11.8 NantHealth
11.8.1 NantHealth Company Details
11.8.2 NantHealth Business Overview
11.8.3 NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.8.4 NantHealth Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.8.5 NantHealth Recent Development
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Details
11.9.2 ARUP Laboratories Business Overview
11.9.3 ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.9.4 ARUP Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.9.5 ARUP Laboratories Recent Development
11.10 Viant Medical
11.10.1 Viant Medical Company Details
11.10.2 Viant Medical Business Overview
11.10.3 Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.10.4 Viant Medical Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.10.5 Viant Medical Recent Development
11.11 Sonic Healthcare
11.11.1 Sonic Healthcare Company Details
11.11.2 Sonic Healthcare Business Overview
11.11.3 Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.11.4 Sonic Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.11.5 Sonic Healthcare Recent Development
11.12 Fulgent Genetics
11.12.1 Fulgent Genetics Company Details
11.12.2 Fulgent Genetics Business Overview
11.12.3 Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.12.4 Fulgent Genetics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.12.5 Fulgent Genetics Recent Development
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Details
11.13.2 Laboratory Corporation of America Holdings Business Overview
11.13.3 Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.13.4 Laboratory Corporation of America Holdings Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.13.5 Laboratory Corporation of America Holdings Recent Development
11.14 BGI Genomics
11.14.1 BGI Genomics Company Details
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.14.4 BGI Genomics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.14.5 BGI Genomics Recent Development
11.15 Daan Gene
11.15.1 Daan Gene Company Details
11.15.2 Daan Gene Business Overview
11.15.3 Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.15.4 Daan Gene Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.15.5 Daan Gene Recent Development
11.16 Guangdong Hybribio Biotech
11.16.1 Guangdong Hybribio Biotech Company Details
11.16.2 Guangdong Hybribio Biotech Business Overview
11.16.3 Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.16.4 Guangdong Hybribio Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.16.5 Guangdong Hybribio Biotech Recent Development
11.17 Jiangsu Bioperfectus Technologies
11.17.1 Jiangsu Bioperfectus Technologies Company Details
11.17.2 Jiangsu Bioperfectus Technologies Business Overview
11.17.3 Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.17.4 Jiangsu Bioperfectus Technologies Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.17.5 Jiangsu Bioperfectus Technologies Recent Development
11.18 Maccura Biotechnology
11.18.1 Maccura Biotechnology Company Details
11.18.2 Maccura Biotechnology Business Overview
11.18.3 Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.18.4 Maccura Biotechnology Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.18.5 Maccura Biotechnology Recent Development
11.19 Guangzhou Wondfo Biotech
11.19.1 Guangzhou Wondfo Biotech Company Details
11.19.2 Guangzhou Wondfo Biotech Business Overview
11.19.3 Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.19.4 Guangzhou Wondfo Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.19.5 Guangzhou Wondfo Biotech Recent Development
11.20 GoBroad Healthcare
11.20.1 GoBroad Healthcare Company Details
11.20.2 GoBroad Healthcare Business Overview
11.20.3 GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Introduction
11.20.4 GoBroad Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
11.20.5 GoBroad Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nucleic Acid Amplification Testing
Table 3. Key Players of Nucleic Acid Hybridization Testing
Table 4. Key Players of Gene Sequencing
Table 5. Key Players of Gene Chip Technology
Table 6. Key Players of Others
Table 7. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region (2020-2025)
Table 11. Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region (2026-2031)
Table 13. Clinical Reference Laboratory Molecular Diagnostic Services Market Trends
Table 14. Clinical Reference Laboratory Molecular Diagnostic Services Market Drivers
Table 15. Clinical Reference Laboratory Molecular Diagnostic Services Market Challenges
Table 16. Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
Table 17. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Players (2020-2025)
Table 19. Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Reference Laboratory Molecular Diagnostic Services as of 2024)
Table 20. Ranking of Global Top Clinical Reference Laboratory Molecular Diagnostic Services Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Clinical Reference Laboratory Molecular Diagnostic Services Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Headquarters and Area Served
Table 23. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Product and Application
Table 24. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Type (2020-2025)
Table 28. Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Type (2026-2031)
Table 30. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Application (2020-2025)
Table 32. Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Application (2026-2031)
Table 34. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Country (2026-2031) & (US$ Million)
Table 49. Quest Diagnostics Company Details
Table 50. Quest Diagnostics Business Overview
Table 51. Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 52. Quest Diagnostics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 53. Quest Diagnostics Recent Development
Table 54. Eurofins Scientific Company Details
Table 55. Eurofins Scientific Business Overview
Table 56. Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 57. Eurofins Scientific Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 58. Eurofins Scientific Recent Development
Table 59. Mayo Clinic Laboratories Company Details
Table 60. Mayo Clinic Laboratories Business Overview
Table 61. Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 62. Mayo Clinic Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 63. Mayo Clinic Laboratories Recent Development
Table 64. Genomic Health Company Details
Table 65. Genomic Health Business Overview
Table 66. Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 67. Genomic Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 68. Genomic Health Recent Development
Table 69. Clinical Reference Laboratory Company Details
Table 70. Clinical Reference Laboratory Business Overview
Table 71. Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 72. Clinical Reference Laboratory Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 73. Clinical Reference Laboratory Recent Development
Table 74. Molecular Pathology Laboratory Network Company Details
Table 75. Molecular Pathology Laboratory Network Business Overview
Table 76. Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 77. Molecular Pathology Laboratory Network Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 78. Molecular Pathology Laboratory Network Recent Development
Table 79. Opko Health Company Details
Table 80. Opko Health Business Overview
Table 81. Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 82. Opko Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 83. Opko Health Recent Development
Table 84. NantHealth Company Details
Table 85. NantHealth Business Overview
Table 86. NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 87. NantHealth Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 88. NantHealth Recent Development
Table 89. ARUP Laboratories Company Details
Table 90. ARUP Laboratories Business Overview
Table 91. ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 92. ARUP Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 93. ARUP Laboratories Recent Development
Table 94. Viant Medical Company Details
Table 95. Viant Medical Business Overview
Table 96. Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 97. Viant Medical Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 98. Viant Medical Recent Development
Table 99. Sonic Healthcare Company Details
Table 100. Sonic Healthcare Business Overview
Table 101. Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 102. Sonic Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 103. Sonic Healthcare Recent Development
Table 104. Fulgent Genetics Company Details
Table 105. Fulgent Genetics Business Overview
Table 106. Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 107. Fulgent Genetics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 108. Fulgent Genetics Recent Development
Table 109. Laboratory Corporation of America Holdings Company Details
Table 110. Laboratory Corporation of America Holdings Business Overview
Table 111. Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 112. Laboratory Corporation of America Holdings Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 113. Laboratory Corporation of America Holdings Recent Development
Table 114. BGI Genomics Company Details
Table 115. BGI Genomics Business Overview
Table 116. BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 117. BGI Genomics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 118. BGI Genomics Recent Development
Table 119. Daan Gene Company Details
Table 120. Daan Gene Business Overview
Table 121. Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 122. Daan Gene Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 123. Daan Gene Recent Development
Table 124. Guangdong Hybribio Biotech Company Details
Table 125. Guangdong Hybribio Biotech Business Overview
Table 126. Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 127. Guangdong Hybribio Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 128. Guangdong Hybribio Biotech Recent Development
Table 129. Jiangsu Bioperfectus Technologies Company Details
Table 130. Jiangsu Bioperfectus Technologies Business Overview
Table 131. Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 132. Jiangsu Bioperfectus Technologies Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 133. Jiangsu Bioperfectus Technologies Recent Development
Table 134. Maccura Biotechnology Company Details
Table 135. Maccura Biotechnology Business Overview
Table 136. Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 137. Maccura Biotechnology Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 138. Maccura Biotechnology Recent Development
Table 139. Guangzhou Wondfo Biotech Company Details
Table 140. Guangzhou Wondfo Biotech Business Overview
Table 141. Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 142. Guangzhou Wondfo Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 143. Guangzhou Wondfo Biotech Recent Development
Table 144. GoBroad Healthcare Company Details
Table 145. GoBroad Healthcare Business Overview
Table 146. GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 147. GoBroad Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 148. GoBroad Healthcare Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 152. Authors List of This Report


List of Figures
Figure 1. Clinical Reference Laboratory Molecular Diagnostic Services Picture
Figure 2. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type: 2024 VS 2031
Figure 4. Nucleic Acid Amplification Testing Features
Figure 5. Nucleic Acid Hybridization Testing Features
Figure 6. Gene Sequencing Features
Figure 7. Gene Chip Technology Features
Figure 8. Others Features
Figure 9. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application: 2024 VS 2031
Figure 11. Disease Diagnosis Case Studies
Figure 12. Drug Development Case Studies
Figure 13. Personalized Healthcare Case Studies
Figure 14. Medicolegal Expertise Case Studies
Figure 15. Others Case Studies
Figure 16. Clinical Reference Laboratory Molecular Diagnostic Services Report Years Considered
Figure 17. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region: 2024 VS 2031
Figure 20. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Players in 2024
Figure 21. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Clinical Reference Laboratory Molecular Diagnostic Services Revenue in 2024
Figure 23. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 25. United States Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 29. Germany Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Region (2020-2031)
Figure 37. China Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 45. Mexico Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Country (2020-2031)
Figure 49. Turkey Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Clinical Reference Laboratory Molecular Diagnostic Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Quest Diagnostics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 53. Eurofins Scientific Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 54. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 55. Genomic Health Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 56. Clinical Reference Laboratory Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 57. Molecular Pathology Laboratory Network Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 58. Opko Health Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 59. NantHealth Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 60. ARUP Laboratories Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 61. Viant Medical Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 62. Sonic Healthcare Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 63. Fulgent Genetics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 64. Laboratory Corporation of America Holdings Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 65. BGI Genomics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 66. Daan Gene Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 67. Guangdong Hybribio Biotech Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 68. Jiangsu Bioperfectus Technologies Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 69. Maccura Biotechnology Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 70. Guangzhou Wondfo Biotech Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 71. GoBroad Healthcare Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock